Precigen Inc. (NASDAQ:PGEN) is one of the 10 Stocks Paying Off Big Time. Precigen rallied for a second day on Monday, surging ...
Precigen Inc. (NASDAQ:PGEN) is one of the penny stocks with explosive growth potential. On June 15, Precigen secured FDA orphan drug exclusivity for PAPZIMEOS, a precision medicine treating adult ...
25y
Precigen Inc
View Precigen Inc PGEN stock quote prices, financial information, real-time forecasts, and company news from CNN.
A downtrend has been apparent in Precigen, Inc. (PGEN) lately. While the stock has lost 19.9% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last ...
On Friday, the U.S. Food and Drug Administration (FDA) approved Precigen Inc.’s (NASDAQ:PGEN) Papzimeos (zopapogene imadenovec-drba) for adult patients with recurrent respiratory papillomatosis (RRP).
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in TTEC Holdings Inc (Symbol: TTEC), where a total of 1,093 contracts have traded so far, ...
Precigen develops gene and cellular therapies, disease-modifying therapeutics, and proprietary platforms such as UltraVector, Sleeping Beauty, UltraCAR-T, and AdenoVerse Immunotherapy. Operates a ...
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, ...
Precigen Inc. company facts, information and financial ratios from MarketWatch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results